pISSN 2234-3806eISSN 2234-3814
Table. 1.
Characteristics of patients with AML with
| Characteristics | Without SM-AHN (N = 19) | With SM-AHN (N = 4) | |
|---|---|---|---|
| Age (yr) | |||
| Median (range) | 43 (4–74) | 38.5 (8–56) | 0.683 |
| Sex, N (%) | |||
| Male | 12 (63.2) | 2 (50) | 1.000 |
| Female | 7 (36.8) | 2 (50) | |
| Hb (g/L) | |||
| Median (range) | 84 (52–116) | 86 (69–101) | 0.892 |
| Leukocytes ( × 109/L) | |||
| Median (range) | 5,810 (750–26,610) | 10,540 (4,690–29,930) | 0.366 |
| Absolute neutrophil count ( × 109/L) | |||
| Median (range) | 1,243 (66–13,017) | 730 (125–1,373) | 0.457 |
| Platelets ( × 109/L) | |||
| Median (range) | 57 (22–110) | 61 (16–81) | 0.953 |
| 3 (15.8) | 3 (75) | 0.040 | |
| D816V | 2 (10.5) | 2 (50) | |
| Other | 1 (5.3) | 1 (25) | |
| Outcome | |||
| Follow-up, months, median (range) | 22 (2–68) | 33 (11–70) | 0.494 |
| Hematopoietic stem cell transplantation, N (%) | 11 (57.9) | 4 (100) | 0.257 |
| Death, N (%) | 2 (11.1) | 1 (25.0) | 0.470 |
Abbreviations: AML, acute myeloid leukemia; SM-AHN, systemic mastocytosis with associated hematological neoplasm.
Ann Lab Med 2022;42:678~682 https://doi.org/10.3343/alm.2022.42.6.678
© Ann Lab Med